Data management in substance use disorder treatment research: Implications from data harmonization of National Institute on Drug Abuse-funded randomized controlled trials

Ryoko Susukida, Masoumeh Aminesmaeili, Ramin Mojtabai
doi: https://doi.org/10.1101/2020.04.28.20081935

Article Information

doi 
https://doi.org/10.1101/2020.04.28.20081935
History 
  • May 3, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Ryoko Susukida, PhD1,*,
  2. Masoumeh Aminesmaeili, MD, MPH1,2 and
  3. Ramin Mojtabai, MD, PhD, MPH1,3
  1. 1Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA
  2. 2Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, No. 486, South Karegar Ave., Tehran, Iran
  3. 3Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 N. Wolfe St. Baltimore, MD 21287
  1. ↵*Corresponding author: Ryoko Susukida, 624 N. Broadway Room 808, Baltimore, MD, 21205, USA, Telephone: 410-502-9344, Fax: 410-614-7469, Email: rsusuki1{at}jhu.edu
Back to top
Posted May 03, 2020.
Download PDF
Data/Code
Email
Data management in substance use disorder treatment research: Implications from data harmonization of National Institute on Drug Abuse-funded randomized controlled trials
Ryoko Susukida, Masoumeh Aminesmaeili, Ramin Mojtabai
medRxiv 2020.04.28.20081935; doi: https://doi.org/10.1101/2020.04.28.20081935
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area